Yi-Ju Chen

Yi-Ju Chen is an accomplished biopharmaceutical professional with over 14 years of experience in biomedical sciences and animal studies, focusing on drug discovery and development.1 She served as a Technology & Resource Development Scientist at The Jackson Laboratory from October 2018 to July 2021, based in Bar Harbor, Maine.1

Key aspects of Yi-Ju Chen's career and expertise include:

1. Pre-clinical research: She has extensive experience in gene and cell therapy, particularly in the field of diabetes.1

2. Project leadership: Chen led preclinical studies to evaluate drug efficacy in mouse models of rare neurodegenerative diseases, collaborating with patient-focused foundations.1

3. Technical skills: She has expertise in characterizing Virus-Like Particle (VLP) vaccines, implementing innovative methods in cell biology and molecular genetics, and developing analytical assays for vaccine product characterization.1

4. Academic background: Chen holds a Ph.D. in Biochemistry and Molecular Genetics from the University of Illinois at Chicago, a Master's degree in Molecular Medicine from National Cheng Kung University, and a Bachelor's degree in Medical Technology from Chung Shan Medical University.1

5. Notable achievements: At The Jackson Laboratory, Chen designed and executed AAV gene-editing studies, identified novel biomarkers using advanced analytical techniques, and secured additional research grant funding from NIH.1

Throughout her career, Yi-Ju Chen has demonstrated strengths in strategic planning, problem-solving, and project leadership, with a focus on developing life-saving therapies and healthcare solutions for patients.1